Acadian Asset Management
CLGN icon

Acadian Asset Management’s CollPlant Biotechnologies CLGN Stock Holding History

Acadian Asset Management’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,446
Closed -$32K – 2237
2020
Q1 		$32K Buy
+3,446
New +$35.4K ﹤0.01% 1592

Other funds holding CLGN

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management's CLGN Position: Q2 2020 in Review

Acadian Asset Management sold out of CollPlant Biotechnologies (CLGN) in Q2 2020, closing a stake of 3,446 shares — an estimated $32K sold.

Acadian Asset Management first reported a position in CLGN in Q1 2020 and held it in 1 quarter. The position peaked at $32K in Q1 2020. 6 funds tracked by Wall St. Rank hold CLGN as of Q2 2020.

  • Acadian Asset Management reported no remaining CollPlant Biotechnologies position as of Q2 2020 after selling out during the quarter.
  • Acadian Asset Management sold 3,446 CollPlant Biotechnologies shares in Q2 2020, an estimated $32K.
  • Acadian Asset Management first reported a position in CollPlant Biotechnologies in Q1 2020 and held it in 1 quarter.
  • Acadian Asset Management's CollPlant Biotechnologies position peaked at $32K in Q1 2020.
  • 6 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2020.

Based on Acadian Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.